Literature DB >> 10335666

Psychoses in the elderly: a spectrum of disorders.

S D Targum1, J L Abbott.   

Abstract

The incidence of psychoses increases with age with a number of factors leading to the increase in vulnerability and expression. They include comorbid physical illnesses, social isolation, sensory deficits, cognitive changes, polypharmacy, and substance abuse. Agitation and aggressiveness are also associated with psychosis in the elderly and frequently are the precipitating reasons for psychiatric consultation. A review of psychoses in the elderly must, therefore, consider psychotic symptoms within the context of the underlying etiologies of the psychotic symptoms. Elderly patients who present with psychotic symptoms require social, behavioral, and environmental interventions that are necessary for their safety and orientation. Given the likelihood of comorbid medical disorders and concomitant medications, the mere presence of delusions or hallucinations is not always an indication for additional medications. However, some patients may need pharmacologic intervention in order to manage the behavioral disturbance that often results from the psychotic symptoms. The atypical antipsychotics with their low propensity to produce extrapyramidal and cognitive side effects have greatly advanced the pharmacotherapy for elderly patients with psychoses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335666

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

1.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

2.  Psychotic symptoms in the elderly.

Authors:  Rebecca W Brendel; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 3.  Antipsychotic medications and the elderly: effects on cognition and implications for use.

Authors:  M J Byerly; M T Weber; D L Brooks; L R Snow; M A Worley; E Lescouflair
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Ary Gadelha; Maura Regina Laureano; Cristiano de Souza Noto; Griselda Jara Garrido; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

Review 5.  The pathology of paraphrenia.

Authors:  Manuel F Casanova
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 6.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 7.  Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia.

Authors:  Dhiren Singh; Daniel W O'Connor
Journal:  Clin Interv Aging       Date:  2009-09-01       Impact factor: 4.458

8.  Use of antipsychotics in older home care patients in Finland.

Authors:  Hanna-Mari Alanen; Harriet Finne-Soveri; Anja Noro; Esa Leinonen
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

9.  Treating Psychotic Symptoms in Elderly Patients.

Authors:  Steven D. Targum
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

10.  Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia.

Authors:  Rosa Catalán; Rafael Penadés
Journal:  J Cent Nerv Syst Dis       Date:  2011-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.